These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2166933)

  • 41. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced expression of autotaxin predicts survival in uveal melanoma.
    Singh AD; Sisley K; Xu Y; Li J; Faber P; Plummer SJ; Mudhar HS; Rennie IG; Kessler PM; Casey G; Williams BG
    Br J Ophthalmol; 2007 Oct; 91(10):1385-92. PubMed ID: 17475713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups.
    Augsburger JJ; Gamel JW; Shields JA
    Trans Am Ophthalmol Soc; 1989; 87():348-59; discussion 359-61. PubMed ID: 2562523
    [No Abstract]   [Full Text] [Related]  

  • 44. Flow cytometry of uveal melanomas.
    Shapiro BE; Felberg NT; Donoso LA; Augsburger JJ; Shields JA; Gamel J
    Cancer Biochem Biophys; 1986 Jul; 8(3):235-8. PubMed ID: 3742483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma.
    Abdel-Rahman MH; Yang Y; Zhou XP; Craig EL; Davidorf FH; Eng C
    J Clin Oncol; 2006 Jan; 24(2):288-95. PubMed ID: 16344319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic associations of insulin-like growth factor-1 receptor in primary uveal melanoma.
    Al-Jamal RT; Kivelä T
    Can J Ophthalmol; 2011 Dec; 46(6):471-6. PubMed ID: 22153631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Enucleations in uveal melanoma (analysis of archival records)].
    Grishina EE; Davydov DV; Stoiukhina AS
    Vestn Oftalmol; 2010; 126(2):30-4. PubMed ID: 21105376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology.
    McLean IW; Foster WD; Zimmerman LE; Gamel JW
    Am J Ophthalmol; 1983 Oct; 96(4):502-9. PubMed ID: 6624832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modifications of Callender's Classification of Uveal Melanoma at the Armed Forces Institute of Pathology.
    McLean IW; Foster WD; Zimmerman LE; Gamel JW
    Am J Ophthalmol; 2018 Nov; 195():lvi-lx. PubMed ID: 30384958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of human uveal melanoma cells by phosphorus 31 nuclear magnetic resonance spectroscopy.
    Kolodny NH; Albert DM; Epstein J; Ruzzo M; Sprengnether M
    Am J Ophthalmol; 1985 Jul; 100(1):38-44. PubMed ID: 4014378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ploidy analysis in uveal melanoma.
    Mooy CM
    Br J Ophthalmol; 1998 Dec; 82(12):1352-3. PubMed ID: 9930261
    [No Abstract]   [Full Text] [Related]  

  • 52. A perfusion system developed for 31P NMR study of melanoma cells at tissue-like density.
    Minichiello MM; Albert DM; Kolodny NH; Lee MS; Craft JL
    Magn Reson Med; 1989 Apr; 10(1):96-107. PubMed ID: 2755337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cultured human keratinocytes: discrimination of different cell cycle compartments based upon measurement of nuclear RNA or total cellular RNA content.
    Staiano-Coico L; Darzynkiewicz Z; McMahon CK
    Cell Tissue Kinet; 1989 May; 22(3):235-43. PubMed ID: 2478288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of primary uveal melanomas using single cell RNA sequencing].
    Grandjean-Closson E; Heckmann C; Le Coz C; Louvet I; Neri M; Bertolotto C
    Med Sci (Paris); 2022; 38(8-9):737-739. PubMed ID: 36094248
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
    Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
    Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flow cytometry measurement of nuclear RNA content in uveal melanoma.
    Chen TC; Char DH; Waldman F; Juster RP
    Ophthalmic Res; 1990; 22(3):187-93. PubMed ID: 2166933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimation of DNA content in uveal melanomas by flow cytometry.
    Rennie IG; Rees RC; Parsons MA; Lawry J; Cottam D
    Eye (Lond); 1989; 3 ( Pt 5)():611-7. PubMed ID: 2630338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA content analysis of uveal melanoma.
    McMillan J; Char DH; McLean IW; Gamel JW
    Arch Ophthalmol; 1989 Sep; 107(9):1278. PubMed ID: 2783056
    [No Abstract]   [Full Text] [Related]  

  • 59. DNA index and S phase fraction in uveal malignant melanomas.
    Hodge WG; Duclos AJ; Rocha G; Antecka E; Baines MG; Corriveau C; Brownstein S; Deschenes J
    Br J Ophthalmol; 1995 Jun; 79(6):521-6. PubMed ID: 7626566
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.